Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)
神经科学临床试验卓越网络的临床研究网站(NeuroNEXT 网站)
基本信息
- 批准号:10744306
- 负责人:
- 金额:$ 46.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgreementApplications GrantsAwardBiological MarkersCareer MobilityCaringChildhoodClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCommunity OutreachComplementConduct Clinical TrialsCountryDataDevelopmentEducationEthnic OriginFoundationsFundingFutureGenderGene therapy trialGenerationsGoalsHealthInfrastructureInstitutionInstitutional Review BoardsInternationalLeadLeadershipLettersLocationMedical centerMedicineMinority GroupsModelingNational Institute of Neurological Disorders and StrokeNetwork InfrastructureNeurologyNeurosciencesParticipantPatient RecruitmentsPatientsPediatric HospitalsPersonsPhase III Clinical TrialsPopulationPredispositionPreparationProductivityProtocols documentationPublicationsRaceRandomizedResearchResearch DesignResearch InfrastructureResearch PersonnelRoleSecureSiteSpecialistStandardizationTestingTrainingUnited States National Institutes of HealthUniversitiesage relatedcareer developmentclinical biomarkersclinical research sitecommunity engagementdesignepidemiology studyequity, diversity, and inclusionexperiencegenetic epidemiologyimplementation facilitationimprovedinnovationmembernervous system disordernovel therapeuticsoutreach programpatient populationphase II trialprogramsrecruitresearch studysexskillssuccesswillingness
项目摘要
CinciNEXT is a unique collaboration between the free-standing Cincinnati Children’s Hospital Medical Center (CCHMC) and the University of Cincinnati (UC) that aims to continue to be a productive clinical site in the NINDS-funded Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) network. The objective of the proposed application is to secure the infrastructural support needed to maintain the outstanding quality of clinical trials that the CinciNEXT site has conducted for the NEXT Network during the first and second cycles of support. Specific goals of CinciNEXT are to facilitate the implementation, enhance recruitment, maximize retention, and optimize study conduct of NeuroNEXT network studies. A second goal is to actively contribute to the overall success of the NeuroNEXT network by participating in network governance, network committees, and network activities. The third goal is to implement a new/junior investigator career advancement program to help them develop skills and experience to participate and/or lead future NeuroNEXT and other NINDS trials. These goals will be achieved by the combination of our experienced CinciNEXT leadership team (two co-PIs and one fulltime research study coordinator with over 9 years of NeuroNEXT experience working together), enthusiastic research collaborators, existing outstanding research infrastructure (including a CTSA), robust breadth and depth of patients available to participate in trials, and two supportive research administrations. Both institutions have shown their commitment to the NeuroNEXT Network by agreeing to continue to use a standardized Master Trial Agreement and employ a Tier 1 level of centralized IRB review. The CinciNEXT clinical site anticipates continuing to provide outstanding recruitment, retention, and quality for NeuroNEXT network trials, and thereby advancing treatments for neurological disorders. CinciNEXT proposes to be a key partner in this NINDS network that has provided a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and pediatric populations.
辛辛那提ext是独立的辛辛那提儿童医院医学中心(CCHMC)和辛辛那提大学(UC)之间的独特合作,旨在继续成为ninds资助的神经科学临床试验卓越网络(NeuroNEXT)网络中富有成效的临床站点。拟议申请的目的是确保在第一和第二周期的支持期间,维持辛辛纳特中心为NEXT网络进行的临床试验的卓越质量所需的基础设施支持。辛辛那提的具体目标是促进实施,加强招聘,最大限度地保留,并优化NeuroNEXT网络研究的研究行为。第二个目标是通过参与网络治理、网络委员会和网络活动,积极为NeuroNEXT网络的整体成功做出贡献。第三个目标是实施一个新的/初级研究员职业发展计划,帮助他们发展技能和经验,以参与和/或领导未来的NeuroNEXT和其他NINDS试验。这些目标将通过我们经验丰富的cincinnati领导团队(两名联合pi和一名全职研究协调员,拥有超过9年的NeuroNEXT工作经验),热情的研究合作者,现有的优秀研究基础设施(包括CTSA),可参与试验的患者的强大广度和深度,以及两个支持性研究管理部门的结合来实现。两家机构都表明了他们对NeuroNEXT网络的承诺,同意继续使用标准化的主试验协议,并采用一级集中式IRB审查。辛辛那提临床站点预计将继续为NeuroNEXT网络试验提供出色的招募、保留和质量,从而推进神经系统疾病的治疗。辛辛那提提议成为该NINDS网络的主要合作伙伴,该网络提供了一个强大的、标准化的和可访问的基础设施,以促进影响成人和儿童人群的神经系统疾病方案的快速开发和实施。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differences in peripheral immune system gene expression in frontotemporal degeneration.
- DOI:10.1097/md.0000000000028645
- 发表时间:2022-01-21
- 期刊:
- 影响因子:1.6
- 作者:Sawyer RP;Hill EJ;Yokoyama J;Medvedovic M;Ren Y;Zhang X;Choubey D;Shatz RS;Miller B;Woo D
- 通讯作者:Woo D
Factors associated with long-term outcomes in pediatric refractory status epilepticus.
- DOI:10.1111/epi.16984
- 发表时间:2021-09
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
Virtual coordinator and site training and reorganization of a multisite consortium upon grant renewal: Challenges of the NeuroNEXT network.
- DOI:10.1016/j.conctc.2021.100821
- 发表时间:2021-09
- 期刊:
- 影响因子:1.5
- 作者:Lowenhaupt S;Molloy A
- 通讯作者:Molloy A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRACY A GLAUSER其他文献
TRACY A GLAUSER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRACY A GLAUSER', 18)}}的其他基金
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
10166966 - 财政年份:2018
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
10593621 - 财政年份:2018
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
8869050 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
9293406 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
8721489 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
T32 Cincinnati Pediatric Clinical Pharmacology Training Program
T32 辛辛那提儿科临床药理学培训计划
- 批准号:
10631893 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
8337819 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
8241271 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
辛辛那提神经科学临床试验研究中心 (CinciNEXT)
- 批准号:
8532063 - 财政年份:2011
- 资助金额:
$ 46.02万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 46.02万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 46.02万 - 项目类别:
Studentship